Bafna Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

115.35

85.14

71.22

42.47

43.36

Operating profit

15.72

11.49

10.30

1.23

-13.34

Interest

2.04

0.79

0.74

0.10

2.13

Gross profit

16.95

12.80

10.31

1.39

-14.81

EPS (Rs)

4.79

2.18

2.46

-106.54

-8.34

Other income

3.27

2.10

0.75

0.26

0.65

Stock adjustment

-2.91

-1.77

2.95

-3.24

0.81

Raw material

59.57

53.06

42.51

30.24

33.29

Power and fuel

-

-

-

-

-

Employee expenses

15.87

14.50

11.98

10.25

9.01

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

27.11

7.86

3.48

3.99

13.58

Provisions made

-

-

-

-

-

Depreciation

5.33

5.49

4.48

3.27

3.42

Taxation

0.28

-

-

-

1.50

Net profit / loss

11.34

5.15

5.83

-25.20

-19.73

Extra ordinary item

-

-2.16

-

-23.33

-

Prior year adjustments

-

-

-

-

-

Equity capital

23.66

23.66

23.66

2.37

23.66

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

13.62

13.50

14.46

2.89

-30.76

GPM (%)

14.29

14.67

14.32

3.25

-33.64

NPM (%)

9.56

5.90

8.10

-58.99

-44.83